Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 19Myelodysplastic Syndromes 8Congenital Abnormalities 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Myeloproliferative Disorders 5Leukemia, Myelomonocytic, Chronic 5Leukemia, Lymphocytic, Chronic, B-Cell 4Leukemia 4Carcinoma, Non-Small-Cell Lung 4Mesothelioma, Malignant 3Lymphoma, Mantle-Cell 3Lymphoma, Large B-Cell, Diffuse 3Lung Neoplasms 3Leukemia, Myelomonocytic, Acute 3Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3Burkitt Lymphoma 3Blast Crisis 3Thrombocythemia, Essential 2Small Cell Lung Carcinoma 2Primary Myelofibrosis 2Polycythemia Vera 2Neoplasm Metastasis 2Myelodysplastic-Myeloproliferative Diseases 2Melanoma 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2

Interventions

Trastuzumab 2Docetaxel 2Carboplatin 2Bortezomib 2tipifarnib 1saracatinib 1Taxes 1Pleurodesis 1Paclitaxel 1Morphine 1LMB-100 1Interleukin-12 Subunit p35 1Interleukin-12 1Ibuprofen 1Gemcitabine 1Erlotinib Hydrochloride 1Decitabine 1Cytoreduction Surgical Procedures 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Pleural Effusion, Malignant × Decitabine × Clear all
NCT00019825 2015-04-29

Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura

National Cancer Institute (NCI)

Phase 1 Completed
GastrointestinalOther solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Pleural Effusion, Malignant, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡